PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
105 hedge funds and large institutions have $133M invested in Aratana Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $138M → $133M (-$5.62M)
Holders
105
Holding in Top 10
1
Calls
$648K
Puts
$159K
Top Buyers
| 1 | +$1.7M | |
| 2 | +$1.55M | |
| 3 | +$1.47M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$717K |
| 5 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$687K |
Top Sellers
| 1 | -$3.46M | |
| 2 | -$2.71M | |
| 3 | -$1.85M | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$1.12M |
| 5 |
Renaissance Technologies
New York
|
-$860K |